New User? Sign Up | Sign In

Insider Trading - Thorp Clay

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Thorp Clay

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-07-01
Sale
2019-07-03
4:28 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
2,908 $14 $40,712 1,818,638
(Indirect)
View
2019-06-18
Sale
2019-06-20
7:09 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
400 $14 $5,600 1,820,656
(Indirect)
View
2018-12-06
Purchase
2018-12-06
5:41 pm
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
8,000 $1.36 $10,880 3,466,394
(Indirect
Direct)
View
2018-12-04
Purchase
2018-12-06
09:15 am
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
4,000 $3.13 $12,520 1,820,933
(Indirect
Direct)
View
2018-10-22
Purchase
2018-10-24
4:19 pm
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
300,000 $5 $1,500,000 1,820,933
(Direct
Indirect)
View
2018-05-30
Sale
2018-06-01
6:22 pm
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
800,000 $48 $38,400,000 3,279,421
(Indirect)
View
2018-05-21
Sale
2018-05-23
8:46 pm
G1 Therapeutics Inc. GTHX Thorp Clay
Hatteras Venture Advisors IV SBIC LLC
Hatteras Venture Partners IV SBIC LP
INGRAM ROBERT ALEXANDER
Crumpler John
LEE KENNETH B JR
Reed Douglas MD
10% Owner
37,500 $51.11 $1,916,678 4,046,206
(Indirect)
View
2018-05-17
Sale
2018-05-21
4:05 pm
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
161,139 $13.08 $2,107,589 3,527,533
(Indirect)
View
2018-03-21
Sale
2018-03-23
5:51 pm
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
138,861 $12.21 $1,695,791 3,666,394
(Indirect)
View
2017-12-05
Sale
2017-12-07
5:10 pm
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
35,000 $6.216 $217,550 3,786,394
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-11-22
Option Award
2019-11-26
4:33 pm
N/A
N/A
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
1,518,026 $1.054 4,984,420
(Indirect)
View
2019-06-20
Option Award
2019-06-24
4:29 pm
N/A
2029-06-19
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
20,000 $1.07 20,000
(Direct)
View
2019-05-09
Option Award
2019-05-13
4:35 pm
N/A
2029-05-09
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
11,000 $13.23 11,000
(Direct)
View
2019-02-27
Option Award
2019-03-01
5:02 pm
N/A
2029-02-27
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
36,000 $3.15 36,000
(Direct)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
52,690 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
1,683,420 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
150,612 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
4,846 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
266,481 $0 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
19,061 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
19,061 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
458 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
1,731 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
1,731 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
42 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
47,458 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
47,458 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
1,139 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
4,309 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
4,309 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
104 $5 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
41,414 $0.12 1,820,933
(Indirect)
View
2018-10-22
Exercise
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
41,414 $0.12 1,820,933
(Indirect)
View
2018-10-22
Sale
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
994 $5 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
52,690 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
42,530 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
3,862 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
4,846 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
174,699 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
13,609 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
1,044,764 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
94,874 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
149,320 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
13,558 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
40,420 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
272,107 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
24,709 $0 1,820,933
(Indirect)
View
2018-10-22
Conversion
2018-10-24
4:19 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS Thorp Clay
Director, 10% Owner
226,061 $0 1,820,933
(Indirect)
View
2018-06-20
Option Award
2018-06-21
5:23 pm
N/A
2028-06-19
Clearside Biomedical Inc. CLSD Thorp Clay
Director, 10% Owner
11,250 $10.74 11,250
(Direct)
View